These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11356602)

  • 1. Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?
    Tiefenbacher CP
    Am J Physiol Heart Circ Physiol; 2001 Jun; 280(6):H2484-8. PubMed ID: 11356602
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis.
    Tiefenbacher CP; Bleeke T; Vahl C; Amann K; Vogt A; Kübler W
    Circulation; 2000 Oct; 102(18):2172-9. PubMed ID: 11056088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin.
    Laursen JB; Somers M; Kurz S; McCann L; Warnholtz A; Freeman BA; Tarpey M; Fukai T; Harrison DG
    Circulation; 2001 Mar; 103(9):1282-8. PubMed ID: 11238274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function.
    Hyndman ME; Verma S; Rosenfeld RJ; Anderson TJ; Parsons HG
    Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2167-72. PubMed ID: 12003825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus.
    Heitzer T; Krohn K; Albers S; Meinertz T
    Diabetologia; 2000 Nov; 43(11):1435-8. PubMed ID: 11126415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.
    Stroes E; Kastelein J; Cosentino F; Erkelens W; Wever R; Koomans H; Lüscher T; Rabelink T
    J Clin Invest; 1997 Jan; 99(1):41-6. PubMed ID: 9011574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin.
    Huang A; Vita JA; Venema RC; Keaney JF
    J Biol Chem; 2000 Jun; 275(23):17399-406. PubMed ID: 10749876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrobiopterin and endothelial nitric oxide synthase activity.
    Cosentino F; Lüscher TF
    Cardiovasc Res; 1999 Aug; 43(2):274-8. PubMed ID: 10536654
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells.
    Barua RS; Ambrose JA; Srivastava S; DeVoe MC; Eales-Reynolds LJ
    Circulation; 2003 May; 107(18):2342-7. PubMed ID: 12707237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible impact of tetrahydrobiopterin and sepiapterin on endothelial dysfunction.
    Blau N; Thöny B
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):913-4; author reply 914-5. PubMed ID: 12740227
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of endotoxin-induced vascular hyporeactivity by 4-amino-tetrahydrobiopterin.
    Gibraeil HD; Dittrich P; Saleh S; Mayer B
    Br J Pharmacol; 2000 Dec; 131(8):1757-65. PubMed ID: 11139456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?
    Yuyun MF; Ng LL; Ng GA
    Microvasc Res; 2018 Sep; 119():7-12. PubMed ID: 29596860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction does not require loss of endothelial nitric oxide synthase.
    Giraldez RR; Panda A; Zweier JL
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H2020-7. PubMed ID: 10843901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants.
    Vásquez-Vivar J; Duquaine D; Whitsett J; Kalyanaraman B; Rajagopalan S
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1655-61. PubMed ID: 12377745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin.
    Bagi Z; Koller A
    J Vasc Res; 2003; 40(1):47-57. PubMed ID: 12644725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepiapterin treatment in atherosclerosis.
    Tarpey MM
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1519-21. PubMed ID: 12377725
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated oxidative stress and endothelial dysfunction in right coronary artery of right ventricular hypertrophy.
    Lu X; Dang CQ; Guo X; Molloi S; Wassall CD; Kemple MD; Kassab GS
    J Appl Physiol (1985); 2011 Jun; 110(6):1674-81. PubMed ID: 21415175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.
    Fukuda Y; Teragawa H; Matsuda K; Yamagata T; Matsuura H; Chayama K
    Heart; 2002 Mar; 87(3):264-9. PubMed ID: 11847169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-arginine, tetrahydrobiopterin, nitric oxide and diabetes.
    Hoang HH; Padgham SV; Meininger CJ
    Curr Opin Clin Nutr Metab Care; 2013 Jan; 16(1):76-82. PubMed ID: 23164986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.